Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease
- PMID: 17245761
- PMCID: PMC6649306
- DOI: 10.1002/jcla.20159
Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease
Abstract
A specific and reliable competitive affinity assay kit has been developed to quantitatively measure neural thread protein (NTP) in first morning urine samples. This assay, called the urine neural thread protein test (UNTP), is a competitive enzyme-linked immunosorbent assay (ELISA) format affinity assay using 32-well microtiter plates. The assay detects UNTP in the 10-60 microg/mL range (an improvement over earlier assays of 10(3) x ), is linear and more reproducible (average coefficient of variation [CV] 6.2% in precision studies). The utility of the assay has been demonstrated in urine samples from patients with Alzheimer's disease (AD) and controls (sensitivity of 90% and specificity of 91%). Test-retest assays of subjects with AD and controls were comparatively stable at intervals of 2 days to 4.5 years, which suggests that positive (elevated) or negative (normal) NTP levels do not fluctuate significantly over time with respect to the cutoff.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
A multi-center blinded prospective study of urine neural thread protein measurements in patients with suspected Alzheimer's disease.J Am Med Dir Assoc. 2007 Jan;8(1):21-30. doi: 10.1016/j.jamda.2006.07.002. Epub 2006 Sep 29. J Am Med Dir Assoc. 2007. PMID: 17210499
-
Development of a Novel Urine Alzheimer-Associated Neuronal Thread Protein ELISA Kit and Its Potential Use in the Diagnosis of Alzheimer's Disease.J Clin Lab Anal. 2016 Jul;30(4):308-14. doi: 10.1002/jcla.21856. Epub 2015 Jun 3. J Clin Lab Anal. 2016. PMID: 26037289 Free PMC article.
-
Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease.Neurol Clin Neurophysiol. 2002;2002(1):2-8. doi: 10.1162/15268740252769709. Neurol Clin Neurophysiol. 2002. PMID: 12028823 Clinical Trial.
-
Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker.J Clin Lab Anal. 1998;12(5):285-8. doi: 10.1002/(sici)1098-2825(1998)12:5<285::aid-jcla6>3.0.co;2-5. J Clin Lab Anal. 1998. PMID: 9773959 Free PMC article.
-
The AD7C-NTP neuronal thread protein biomarker for detecting Alzheimer's disease.Front Biosci. 2002 Apr 1;7:d989-96. doi: 10.2741/monte. Front Biosci. 2002. PMID: 11897561 Review.
Cited by
-
Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.J Alzheimers Dis. 2017;60(1):87-95. doi: 10.3233/JAD-170383. J Alzheimers Dis. 2017. PMID: 28777752 Free PMC article.
-
Advances in the development paradigm of biosample-based biosensors for early ultrasensitive detection of alzheimer's disease.J Nanobiotechnology. 2021 Mar 9;19(1):72. doi: 10.1186/s12951-021-00814-7. J Nanobiotechnology. 2021. PMID: 33750392 Free PMC article. Review.
-
CSF Biomarkers for Alzheimer's Disease Diagnosis.Int J Alzheimers Dis. 2010 Jun 23;2010:606802. doi: 10.4061/2010/606802. Int J Alzheimers Dis. 2010. PMID: 20721349 Free PMC article.
-
Urinary AD7c-NTP Evaluates Cognition Impairment and Differentially Diagnoses AD and MCI.Am J Alzheimers Dis Other Demen. 2022 Jan-Dec;37:15333175221115247. doi: 10.1177/15333175221115247. Am J Alzheimers Dis Other Demen. 2022. PMID: 35833655 Free PMC article.
-
Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.Biochim Biophys Acta. 2008 Oct;1782(10):549-58. doi: 10.1016/j.bbadis.2008.07.008. Epub 2008 Aug 7. Biochim Biophys Acta. 2008. PMID: 18760351 Free PMC article. Review.
References
-
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 Census. Arch Neurol 2003;60:1119–1122. - PubMed
-
- Cummings JL. Alzheimer's disease. N Engl J Med 2004;351:56–67. - PubMed
-
- Jorst BC, Grossberg GT. The natural history of Alzheimer's disease: a brain bank study. J Am Geriatr Soc 1995;43:1248–1255. - PubMed
-
- Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein EE4 association with dementia in a population‐based study: the Framingham study. Neurology 1996;46:673–677. - PubMed
-
- Pirtilla T, Kim KS, Mehta PD, et al. Soluble amyloid‐β‐protein in the cerebrospinal fluid of patients with Alzheimer's disease, vascular dementia and controls. J Neurol Sci 1994;127:90–95. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical